{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:28:17Z","timestamp":1780050497591,"version":"3.53.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.2169\/internalmedicine.2642-23","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T22:12:43Z","timestamp":1699222363000},"page":"1697-1702","source":"Crossref","is-referenced-by-count":2,"title":["Gastric Mucosa-associated Lymphoid Tissue Lymphoma That Relapsed after 11 Years Subsequent to Achieving Complete Remission"],"prefix":"10.2169","volume":"63","author":[{"given":"Shoko","family":"Inoo","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Iwamuro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Practical Gastrointestinal Endoscopy, Okayama University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Ootuka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakamura S, Hojo M. Diagnosis and treatment for gastric mucosa-associated lymphoid tissue (MALT) lymphoma. J Clin Med 12: 120, 2022.","DOI":"10.3390\/jcm12010120"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of <i>Helicobacter pylori<\/i>. Lancet 342: 575-577, 1993.","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bayerd\u00f6rffer E, Miehlke S, Neubauer A, Stolte M. Gastric MALT-lymphoma and <i>Helicobacter pylori<\/i> infection. Aliment Pharmacol Ther 11: 89-94, 1997.","DOI":"10.1046\/j.1365-2036.11.s1.12.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rohatiner A, d&apos;Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 53: 397-400, 1994.","DOI":"10.1093\/oxfordjournals.annonc.a058869"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zullo A, Hassan C, Cristofari F, et al. Effects of <i>Helicobacter pylori<\/i> eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8: 105-110, 2010.","DOI":"10.1016\/j.cgh.2009.07.017"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Ruskon\u00e9-Fourmestraux A, Fischbach W, Aleman BM, et al. EGILS consensus report. Gastric extra nodal marginal zone B-cell lymphoma of MALT. Gut 60: 747-758, 2011.","DOI":"10.1136\/gut.2010.224949"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ferreri AJM, Cecchetti C, Kiesewetter B, et al. Clarithromycin as a &quot;repurposing drug&quot; against MALT lymphoma. Br J Haematol 182: 913-915, 2018.","DOI":"10.1111\/bjh.14878"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gisbert JP, Calvet X. Review article: common misconceptions in the management of <i>Helicobacter pylori<\/i>-associated gastric MALT-lymphoma. Aliment Pharmacol Ther 34: 1047-1062, 2011.","DOI":"10.1111\/j.1365-2036.2011.04839.x"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Takigawa H, Yuge R, Masaki S, et al. Involvement of non-<i>Helicobacter pylori<\/i> helicobacter infections in <i>Helicobacter pylori<\/i>-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. Gastric Cancer 24: 937-945, 2021.","DOI":"10.1007\/s10120-021-01172-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Toyoda K, Maeshima AM, Nomoto J, et al. Mucosa-associated lymphoid tissue lymphoma with t (11;18) (q21;q21) translocation: long-term follow-up results. Ann Hematol 98: 1675-1687, 2019.","DOI":"10.1007\/s00277-019-03671-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Taji S, Nomura K, Matsumoto Y, et al. Trisomy 3 may predict a poor response of gastric MALT lymphoma to <i>Helicobacter pylori<\/i> eradication therapy. World J Gastroenterol 11: 89-93, 2005.","DOI":"10.3748\/wjg.v11.i1.89"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishikawa H, Iwamuro M, Okada H, et al. Recurrence after radiotherapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma with trisomy 18. Intern Med 54: 911-916, 2015.","DOI":"10.2169\/internalmedicine.54.3784"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iwamuro M, Takenaka R, Nakagawa M, et al. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the <i>MALT1<\/i> gene. World J Gastroenterol 23: 6155-6163, 2017.","DOI":"10.3748\/wjg.v23.i33.6155"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Krugmann J, Tzankov A, Dirnhofer S, et al. Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t (11;18) negative, surgically resected, gastrointestinal B cell lymphomas. J Clin Pathol 57: 360-364, 2004.","DOI":"10.1136\/jcp.2003.012369"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Remstein ED, Kurtin PJ, James CD, et al. Mucosa-associated lymphoid tissue lymphomas with t (11;18) (q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 161: 63-71, 2002.","DOI":"10.1016\/S0002-9440(10)64157-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Raderer M, W\u00f6hrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24: 3136-3141, 2006.","DOI":"10.1200\/JCO.2006.06.0723"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Nakamura S, Ye H, Bacon CM, et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence <i>in situ<\/i> hybridisation. Gut 56: 1358-1363, 2007.","DOI":"10.1136\/gut.2007.123729"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Savio A, Zamboni G, Capelli P, et al. Relapse of low-grade gastric MALT lymphoma after <i>Helicobacter pylori<\/i> eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol&apos;s adequacy. Recent Results Cancer Res 156: 116-124, 2000.","DOI":"10.1007\/978-3-642-57054-4_15"},{"key":"19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"19. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of <i>Helicobacter pylori<\/i>: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61: 507-513, 2012.","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2642-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:29:41Z","timestamp":1718422181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/12\/63_2642-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2642-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"article-number":"2642-23"}}